Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 90100 vs Daivobet in Adult Chinese Subjects With Stable Plaque Psoriasis
NCT05919082Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Jun 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calcipotriol + betamethasone in plaque psoriasis, sponsored by LEO Pharma. Started Jun 2023; status: completed.
02
Drugs
calcipotriol + betamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05919082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05919082.